ENDOSURE Trademark

Trademark Overview

On Tuesday, June 14, 2022, a trademark application was filed for ENDOSURE with the United States Patent and Trademark Office. The USPTO has given the ENDOSURE trademark a serial number of 97456714. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 3, 2024. This trademark is owned by 3CPM Company, Inc.. The ENDOSURE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the fields of gastroenterology, gynecology, urology
endosure

General Information

Serial Number97456714
Word MarkENDOSURE
Filing DateTuesday, June 14, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Pseudo MarkENDO SURE
Goods and ServicesMedical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the fields of gastroenterology, gynecology, urology

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 27, 2022
Primary Code044
First Use Anywhere DateSaturday, July 30, 2022
First Use In Commerce DateSaturday, July 30, 2022

Trademark Owner History

Party Name3CPM Company, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSparks Glencoe, MD 21152
Party Name3CPM Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSparks Glencoe, MD 21152

Trademark Events

Event DateEvent Description
Wednesday, January 3, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 3, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 3, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 18, 2023NON-FINAL ACTION E-MAILED
Monday, September 18, 2023SU - NON-FINAL ACTION - WRITTEN
Sunday, September 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 7, 2023USE AMENDMENT FILED
Sunday, September 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 7, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 26, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, June 14, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 22, 2023LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, March 22, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Friday, September 23, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, September 23, 2022ASSIGNED TO LIE
Thursday, August 18, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, June 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 17, 2022NEW APPLICATION ENTERED

Related Keywords

endosure medical testing diagnostic treatment purposes urology gastroenterology gynecology services monitoring